Arginine-rich peptides: Potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms

International Journal of Pharmaceutics

Volumn 245, Issue 1-2, 2002, Pages 1-7

  Futaki, Shiroh ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Arginine rich peptides; Macromolecules; Translocation mechanisms

Indexed keywords

ARGININE; PEPTIDE; TRANSACTIVATOR PROTEIN;

CELL MEMBRANE; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRACELLULAR TRANSPORT; MEMBRANE TRANSPORT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PROTEIN TRANSPORT; REVIEW;

EID: 0036804013     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00337-X     Document Type: Review

References (34)

1. Abu-Amer Y., Dowdy S.F., Ross F.P., Clohisy J.C., Teitelbaum S.L. TAT fusion proteins containing tyrosine 42-deleted IkappaBalpha arrest osteoclastogenesis. J. Biol. Chem. 276:2001;30 499-30 503.
2. Astriab-Fisher A., Sergueev D.S., Fisher M., Shaw B.R., Juliano R.L. Antisense inhibition of P-glycoprotein expression using peptide-oligonucleotide conjugates. Biochem. Pharmacol. 60:2000;83-90.
3. Calnan B.J., Tidor B., Biancalana S., Hudson D., Frankel A.D. Arginine-mediated RNA recognition: the arginine fork. Science. 252:1991;1167-1171.
4. 7. Chem. Biol. 8:2001a;1123-1129.
5. Chen L., Hahn H., Wu G., Chen C.H., Liron T., Schechtman D., Cavallaro G., Banci L., Guo Y., Bolli R., Dorn G.W. II, Mochly-Rosen D. Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and εPKC. Proc. Natl. Acad. Sci. USA. 98:2001b;11 114-11 119.
6. Derossi D., Joliot A.H., Chassaing G., Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269:1994;10 444-10 450.
7. Dostmann W.R., Taylor M.S., Nickl C.K., Brayden J.E., Frank R., Tegge W.J. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. Proc. Natl. Acad. Sci. USA. 97:2000;14 772-14 777.
8. Ezhevsky S.A., Nagahara H., Vocero-Akbani A.M., Gius D.R., Wei M.C., Dowdy S.F. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc. Natl. Acad. Sci. USA. 94:1997;10 699-10 704.
9. Ezhevsky S.A., Ho A., Becker-Hapak M., Davis P.K., Dowdy S.F. Differential regulation of retinoblastoma tumor suppressor protein by G1 cyclin-dependent kinase complexes in vivo. Mol. Cell. Biol. 21:2001;4773-4784.
10. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA. 91:1994;664-668.
11. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., Sugiura Y. Arginine-rich peptides: an abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276:2001;5836-5840.
12. Futaki, S., Nakase, I., Suzuki, T., Zhang, Y., Sugiura, Y., 2002. Translocation of branched-chain arginine peptides through cell membranes: flexibility in the spatial disposition of positive charges in membrane-permeable peptides. Biochemistry 41, 7925-7930.
13. Holinger E.P., Chittenden T., Lutz R.J. Bak BH3 peptides antagonize Bcl-xL function and induce apoptosis through cytochrome c-independent activation of caspases. J. Biol. Chem. 274:1999;13 298-13 304.
14. Josephson L., Tung C.H., Moore A., Weissleder R. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug. Chem. 10:1999;186-191.
15. INK4A fusion protein to human diploid fibroblasts. FEBS Lett. 427:1998;203-208.
16. Kelemen B.R., Hsiao K., Goueli S.A. Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides. J. Biol. Chem. 277:2002;8741-8748.
17. Lee H.J., Pardridge W.M. Pharmacokinetics and delivery of tat and tat-protein conjugates to tissues in vivo. Bioconjug. Chem. 12:2001;995-999.
18. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., Weissleder R. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol. 18:2000;410-414.
19. Matsushita M., Tomizawa K., Moriwaki A., Li S.T., Terada H., Matsui H. A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J. Neurosci. 21:2001;6000-6007.
20. May M.J., D'Acquisto F., Madge L.A., Glockner J., Pober J.S., Ghosh S. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science. 289:2000;1550-1554.
21. Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Peptide Res. 56:2000;318-325.
22. Kip1 induces cell migration. Nat. Med. 4:1998;1449-1452.
23. Polyakov V., Sharma V., Dahlheimer J.L., Pica C.M., Luker G.D., Piwnica-Worms D. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjug. Chem. 11:2000;762-771.
24. Prochiantz A. Messenger proteins: homeoproteins, TAT and others. Curr. Opin. Cell. Biol. 12:2000;400-406.
25. Rothbard J.B., Garlington S., Lin Q., Kirschberg T., Kreider E., McGrane P.L., Wender P.A., Khavari P.A. Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat. Med. 6:2000;1253-1257.
26. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572.
27. Silhol M., Tyagi M., Giacca M., Lebleu B., Vivès E. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur. J. Biochem. 269:2002;494-501.
28. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277:2002;2437-2443.
29. Torchilin V.P., Rammohan R., Weissig V., Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. USA. 98:2001;8786-8791.
30. Umezawa N., Gelman M.A., Haigis M.C., Raines R.T., Gellman S.H. Translocation of a β-peptide across cell membranes. J. Am. Chem. Soc. 124:2002;368-369.
31. Vivès E., Brodin P., Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272:1997;16 010-16 017.
32. Vocero-Akbani A.M., Heyden N.V., Lissy N.A., Ratner L., Dowdy S.F. Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat. Med. 5:1999;29-33.
33. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. USA. 97:2000;13 003-13 008.
34. Wunderbaldinger P., Josephson L., Weissleder R. Tat Peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug. Chem. 13:2002;264-268.